BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22740885)

  • 1. Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds.
    El-Masry OS; Brown BL; Dobson PR
    Oncol Lett; 2012 Jan; 3(1):224-228. PubMed ID: 22740885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK Activation of Apoptotic Markers in Human Breast Cancer Cell Lines with Different p53 Backgrounds: MCF-7, MDA-MB-231 and T47D Cells.
    El-Masry OS; Brown BL; Dobson PRM
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3763-3770. PubMed ID: 31870119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
    Al-Moujahed A; Nicolaou F; Brodowska K; Papakostas TD; Marmalidou A; Ksander BR; Miller JW; Gragoudas E; Vavvas DG
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4175-85. PubMed ID: 24781943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
    Liu S; Tang Y; Yan M; Jiang W
    Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle.
    Hadad SM; Hardie DG; Appleyard V; Thompson AM
    Clin Transl Oncol; 2014 Aug; 16(8):746-52. PubMed ID: 24338509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status.
    Wang YA; Johnson SK; Brown BL; McCarragher LM; Al-Sakkaf K; Royds JA; Dobson PR
    Int J Cancer; 2008 Oct; 123(7):1536-44. PubMed ID: 18634052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
    Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
    Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
    Rattan R; Giri S; Singh AK; Singh I
    J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells.
    Woollhead AM; Scott JW; Hardie DG; Baines DL
    J Physiol; 2005 Aug; 566(Pt 3):781-92. PubMed ID: 15919715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine monophosphate activated protein kinase (AMPK), a mediator of estradiol-induced apoptosis in long-term estrogen deprived breast cancer cells.
    Chen H; Wang JP; Santen RJ; Yue W
    Apoptosis; 2015 Jun; 20(6):821-30. PubMed ID: 25721362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway.
    Morishita M; Kawamoto T; Hara H; Onishi Y; Ueha T; Minoda M; Katayama E; Takemori T; Fukase N; Kurosaka M; Kuroda R; Akisue T
    Int J Oncol; 2017 Jan; 50(1):23-30. PubMed ID: 27878239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cancer Effects of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside (AICAR) on Triple-negative Breast Cancer (TNBC) Cells: Mitochondrial Modulation as an Underlying Mechanism.
    Tripathi V; Jaiswal P; Assaiya A; Kumar J; Parmar HS
    Curr Cancer Drug Targets; 2022; 22(3):245-256. PubMed ID: 35135451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
    Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
    PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner.
    Zhong ZF; Tan W; Qiang WW; Scofield VL; Tian K; Wang CM; Qiang WA; Wang YT
    Mol Biosyst; 2016 Apr; 12(5):1626-37. PubMed ID: 26987443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
    Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
    J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
    PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.
    Kim WG; Choi HJ; Kim TY; Shong YK; Kim WB
    Korean J Intern Med; 2014 Jul; 29(4):474-81. PubMed ID: 25045295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.